Partial microglial depletion attenuates Purkinje cell degeneration and reshapes both glial and inflammatory responses in a mouse model of selective neurodegeneration

Background The microglial population contributes to the inflammatory environment during neurodegeneration. Its role in neuronal loss remains hard to distinguish from its response to injury. We investigated how early pharmacological reduction of this population affects Purkinje cell preservation, behaviour and the cerebellar glial response. Methods We administered PLX5622 to Purkinje cell degeneration (PCD) and wild-type (WT) mice from postnatal day (P) 15 to P24 and compared them with their respective untreated controls. We assessed motor coordination, spontaneous behaviours and novel-object recognition at P17, P21 and P25. At P25, we quantified regional Purkinje cell preservation, glial immunoreactivity and microglial abundance and morphology. We assessed selected transcripts in whole-cerebellum samples by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results At P25, treated PCD mice showed better motor coordination, improvements in selected spontaneous behaviours and greater novel-object discrimination. Greater Purkinje cell preservation coincided with lower glial fibrillary acidic protein (GFAP) immunoreactivity in lobes IV-V and VIII. Microglial density decreased in all four PCD regions analysed. The territory encompassed by the processes of residual microglia expanded in both genotypes. In PCD mice, CD68-positive tissue area decreased in lobes I-II and IV-V, and the proportion of Iba1-positive area occupied by CD68 decreased in IV-V. CD45, CD16/32 and CD206 immunoreactivity decreased alongside selective reductions in immune, inflammatory and phagocytosis-associated transcripts. Treated WT mice showed early behavioural changes, including reduced novel-object discrimination. Conclusions Early PLX5622 treatment can modify the outcome of genetically driven cerebellar degeneration in PCD mice. The benefits achieved with partial microglial depletion provide a preclinical rationale for testing how the timing and extent of glial modulation influence neuronal protection during active degeneration.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.14.766652
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Partial microglial depletion attenuates Purkinje cell degeneration and reshapes both glial and inflammatory responses in a mouse model of selective neurodegeneration

Eduardo Weruaga, David Díaz, David Pérez-Boyero, Jorge Valero et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Neuroinflammation and Neurodegeneration Mechanisms
preprint

Partial microglial depletion attenuates Purkinje cell degeneration and reshapes both glial and inflammatory responses in a mouse model of selective neurodegeneration

Eduardo Weruaga, David Díaz, David Pérez-Boyero, Jorge Valero, Jimena Perez-Arevalo
preprint en

Abstract

Background The microglial population contributes to the inflammatory environment during neurodegeneration. Its role in neuronal loss remains hard to distinguish from its response to injury. We investigated how early pharmacological reduction of this population affects Purkinje cell preservation, behaviour and the cerebellar glial response. Methods We administered PLX5622 to Purkinje cell degeneration (PCD) and wild-type (WT) mice from postnatal day (P) 15 to P24 and compared them with their respective untreated controls. We assessed motor coordination, spontaneous behaviours and novel-object recognition at P17, P21 and P25. At P25, we quantified regional Purkinje cell preservation, glial immunoreactivity and microglial abundance and morphology. We assessed selected transcripts in whole-cerebellum samples by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Results At P25, treated PCD mice showed better motor coordination, improvements in selected spontaneous behaviours and greater novel-object discrimination. Greater Purkinje cell preservation coincided with lower glial fibrillary acidic protein (GFAP) immunoreactivity in lobes IV-V and VIII. Microglial density decreased in all four PCD regions analysed. The territory encompassed by the processes of residual microglia expanded in both genotypes. In PCD mice, CD68-positive tissue area decreased in lobes I-II and IV-V, and the proportion of Iba1-positive area occupied by CD68 decreased in IV-V. CD45, CD16/32 and CD206 immunoreactivity decreased alongside selective reductions in immune, inflammatory and phagocytosis-associated transcripts. Treated WT mice showed early behavioural changes, including reduced novel-object discrimination. Conclusions Early PLX5622 treatment can modify the outcome of genetically driven cerebellar degeneration in PCD mice. The benefits achieved with partial microglial depletion provide a preclinical rationale for testing how the timing and extent of glial modulation influence neuronal protection during active degeneration.

bioRxiv (Cold Spring Harbor Laboratory)
Universidad de Salamanca (ES), Instituto de Neurociencias de Castilla y León (ES)
Good health and well-being
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon